期刊文献+

经阴道超声评价曼月乐治疗子宫内膜增生过长的临床研究 被引量:1

Clinical Study on Transvaginal Ultrasound in Evaluating Mirena in the Treatment of Endometrial Hyperplasia
下载PDF
导出
摘要 目的探讨经阴道超声在曼月乐(左炔诺孕酮宫内缓释系统)治疗子宫内膜增生过长效果评价中的价值。方法选取2015年3月至2018年2月我院收治的53例子宫内膜增生过长患者,用经阴道超声测量曼月乐放置前及放置6个月后的子宫内膜厚度、子宫动脉阻力指数及搏动指数。结果 53例子宫内膜增生过长患者中, 49例患者内膜转归正常,治疗成功率为92.45%。放置6个月后,患者的子宫内膜厚度、子宫动脉阻力指数及搏动指数均明显低于放置前(P <0.05)。结论经阴道超声可较好地评价曼月乐对子宫内膜增生过长的临床治疗效果,尤其是子宫动脉频谱能够直观有效地反映子宫内膜变化,临床应用价值较高。 Objective To explore the value of transvaginal ultrasound in effect evaluation of mirena(levonorgestrel releasing intrauterine system) in the treatment of endometrial hyperplasia. Methods 53 cases of patients with endometrial hyperplasia admitted to our hospital from March 2015 to February 2018 were selected. The endometrium thickness, uterine artery resistance index and pulsatility index before and 6 months after mirena placement were measured by transvaginal ultrasound. Results Among 53 cases of patients with endometrial hyperplasia, 49 cases had normal endometrium, with the treatment success rate of 92.45%. 6 months after placement, the endometrial thickness, uterine artery resistance index and pulsatility index were significantly lower than those before placement(P<0.05).Conclusions Transvaginal ultrasound can be better used to evaluate the clinical treatment effect of mirena on endometrial hyperplasia,especially the uterine artery frequency spectrum can reflect the changes of endometrium directly and effectively, with higher clinical application value.
作者 黄艺 吴洲 聂莉 HUANG Yi;WU Zhou;NIE Li(Department of Ultrasound, Shekou People Is Hospital of Nans han District, Shenzhen 518067,China;Department of Radliolog,Xili People's Hospital qf Nans han District, Shenzhen 518000, China)
出处 《临床医学工程》 2019年第5期569-570,共2页 Clinical Medicine & Engineering
基金 2011年度深圳市南山区科技发展专项资金资助项目(南卫2011049)
关键词 经阴道超声 曼月乐 子宫内膜增生过长 阻力指数 搏动指数 Transvaginal ultrasound Mirena Endometrial hyperplasia Resistance index Pulsatility index
  • 相关文献

参考文献8

二级参考文献72

  • 1邓姗,郎景和.左炔诺孕酮宫内缓释系统的临床功用及相关基础研究[J].国外医学(妇产科学分册),2004,31(5):285-288. 被引量:148
  • 2盛洁,卢丹,张建萍,崔桂芬.左炔诺孕酮宫内释放系统治疗子宫腺肌病痛经的临床观察[J].中华妇产科杂志,2006,41(7):467-470. 被引量:83
  • 3谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 4傅韵,蒋蓓琦,武羿等.左炔诺孕酮宫内缓释系统降低他莫西芬引起的子宫内膜病变的研究[J].中华临床医师杂志(电子版),2011,(15):6949-6953.
  • 5Guven M, Dikmen Y, Terek MC, et al. Metabolic effects associated with high - dose continuous megestrol acetate ad- ministration in the treatment of endometrial pathology [J] . Arch Gynecol Obstet, 2001, 265 (4) : 183 - 186.
  • 6周先荣.诊断子宫内膜增生过长的影响因素及其与子宫内膜癌的关系[J].实用妇产科杂志,2007,23(11):650-651. 被引量:8
  • 7Kim M R, Kim A, Jo M Y, et al. High frequency of endometrial polyps in endometrioais. J Am Assoe Gynecol Laparosc, 2003, l0 ( 1 ) :46 - 4-8.
  • 8Lopes R G,Baracat E C,de Albuquerque Neto L C,et al. Analysis of estrogen and progesterone receptor expression in endometrial polyps. J Minim tnvasive Gynecol,2007,14:300 - 303.
  • 9Backman T. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Drug Saf,2004,27(15) :1185 -1204.
  • 10Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel - releasing intrauterine device. Ann Med, 1990,22:85 - 90.

共引文献121

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部